img

Global Small Molecule Nucleic Acid Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Small Molecule Nucleic Acid Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Small Molecule Nucleic Acid Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Small Molecule Nucleic Acid Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Specialty Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Small Molecule Nucleic Acid Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Small Molecule Nucleic Acid Drug key manufacturers include Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, Novartis, Nippon Shinyaku and Swedish Orphan Biovitrum, etc. Biogen, Pfizer, Jazz are top 3 players and held % sales share in total in 2022.
Small Molecule Nucleic Acid Drug can be divided into Antisense Nucleic Acid (ASO), Small Interfering Nucleic Acid (siRNA), MicroRNA (miRNA) and Nucleic Acid Aptamer (Aptamer), etc. Antisense Nucleic Acid (ASO) is the mainstream product in the market, accounting for % sales share globally in 2022.
Small Molecule Nucleic Acid Drug is widely used in various fields, such as Hospital, Specialty Clinic and Others,, etc. Hospital provides greatest supports to the Small Molecule Nucleic Acid Drug industry development. In 2022, global % sales of Small Molecule Nucleic Acid Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Small Molecule Nucleic Acid Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biogen
Pfizer
Jazz
Sarepta Therapeutics
Alnylam
Novartis
Nippon Shinyaku
Swedish Orphan Biovitrum
Segment by Type
Antisense Nucleic Acid (ASO)
Small Interfering Nucleic Acid (siRNA)
MicroRNA (miRNA)
Nucleic Acid Aptamer (Aptamer)
Transfer RNA (tRNA) Fragmentation

Segment by Application


Hospital
Specialty Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Small Molecule Nucleic Acid Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Small Molecule Nucleic Acid Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Small Molecule Nucleic Acid Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Small Molecule Nucleic Acid Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Small Molecule Nucleic Acid Drug introduction, etc. Small Molecule Nucleic Acid Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Small Molecule Nucleic Acid Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Small Molecule Nucleic Acid Drug Market Overview
1.1 Small Molecule Nucleic Acid Drug Product Overview
1.2 Small Molecule Nucleic Acid Drug Market Segment by Type
1.2.1 Antisense Nucleic Acid (ASO)
1.2.2 Small Interfering Nucleic Acid (siRNA)
1.2.3 MicroRNA (miRNA)
1.2.4 Nucleic Acid Aptamer (Aptamer)
1.2.5 Transfer RNA (tRNA) Fragmentation
1.3 Global Small Molecule Nucleic Acid Drug Market Size by Type
1.3.1 Global Small Molecule Nucleic Acid Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Small Molecule Nucleic Acid Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Small Molecule Nucleic Acid Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Small Molecule Nucleic Acid Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Small Molecule Nucleic Acid Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Small Molecule Nucleic Acid Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Small Molecule Nucleic Acid Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Small Molecule Nucleic Acid Drug Sales Breakdown by Type (2024-2024)
2 Global Small Molecule Nucleic Acid Drug Market Competition by Company
2.1 Global Top Players by Small Molecule Nucleic Acid Drug Sales (2024-2024)
2.2 Global Top Players by Small Molecule Nucleic Acid Drug Revenue (2024-2024)
2.3 Global Top Players by Small Molecule Nucleic Acid Drug Price (2024-2024)
2.4 Global Top Manufacturers Small Molecule Nucleic Acid Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Small Molecule Nucleic Acid Drug Market Competitive Situation and Trends
2.5.1 Small Molecule Nucleic Acid Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Small Molecule Nucleic Acid Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Nucleic Acid Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Small Molecule Nucleic Acid Drug Market
2.8 Key Manufacturers Small Molecule Nucleic Acid Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Small Molecule Nucleic Acid Drug Status and Outlook by Region
3.1 Global Small Molecule Nucleic Acid Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Small Molecule Nucleic Acid Drug Historic Market Size by Region
3.2.1 Global Small Molecule Nucleic Acid Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Small Molecule Nucleic Acid Drug Sales in Value by Region (2024-2024)
3.2.3 Global Small Molecule Nucleic Acid Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Small Molecule Nucleic Acid Drug Forecasted Market Size by Region
3.3.1 Global Small Molecule Nucleic Acid Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Small Molecule Nucleic Acid Drug Sales in Value by Region (2024-2034)
3.3.3 Global Small Molecule Nucleic Acid Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Small Molecule Nucleic Acid Drug by Application
4.1 Small Molecule Nucleic Acid Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Specialty Clinic
4.1.3 Others
4.2 Global Small Molecule Nucleic Acid Drug Market Size by Application
4.2.1 Global Small Molecule Nucleic Acid Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Small Molecule Nucleic Acid Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Small Molecule Nucleic Acid Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Small Molecule Nucleic Acid Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Small Molecule Nucleic Acid Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Small Molecule Nucleic Acid Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Small Molecule Nucleic Acid Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Small Molecule Nucleic Acid Drug Sales Breakdown by Application (2024-2024)
5 North America Small Molecule Nucleic Acid Drug by Country
5.1 North America Small Molecule Nucleic Acid Drug Historic Market Size by Country
5.1.1 North America Small Molecule Nucleic Acid Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2024)
5.2 North America Small Molecule Nucleic Acid Drug Forecasted Market Size by Country
5.2.1 North America Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2034)
6 Europe Small Molecule Nucleic Acid Drug by Country
6.1 Europe Small Molecule Nucleic Acid Drug Historic Market Size by Country
6.1.1 Europe Small Molecule Nucleic Acid Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2024)
6.2 Europe Small Molecule Nucleic Acid Drug Forecasted Market Size by Country
6.2.1 Europe Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Small Molecule Nucleic Acid Drug by Region
7.1 Asia-Pacific Small Molecule Nucleic Acid Drug Historic Market Size by Region
7.1.1 Asia-Pacific Small Molecule Nucleic Acid Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Small Molecule Nucleic Acid Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Small Molecule Nucleic Acid Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Small Molecule Nucleic Acid Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Small Molecule Nucleic Acid Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Small Molecule Nucleic Acid Drug Sales in Value by Region (2024-2034)
8 Latin America Small Molecule Nucleic Acid Drug by Country
8.1 Latin America Small Molecule Nucleic Acid Drug Historic Market Size by Country
8.1.1 Latin America Small Molecule Nucleic Acid Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2024)
8.2 Latin America Small Molecule Nucleic Acid Drug Forecasted Market Size by Country
8.2.1 Latin America Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Small Molecule Nucleic Acid Drug by Country
9.1 Middle East and Africa Small Molecule Nucleic Acid Drug Historic Market Size by Country
9.1.1 Middle East and Africa Small Molecule Nucleic Acid Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Small Molecule Nucleic Acid Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Small Molecule Nucleic Acid Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Small Molecule Nucleic Acid Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Biogen
10.1.1 Biogen Company Information
10.1.2 Biogen Introduction and Business Overview
10.1.3 Biogen Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Biogen Small Molecule Nucleic Acid Drug Products Offered
10.1.5 Biogen Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Pfizer Small Molecule Nucleic Acid Drug Products Offered
10.2.5 Pfizer Recent Development
10.3 Jazz
10.3.1 Jazz Company Information
10.3.2 Jazz Introduction and Business Overview
10.3.3 Jazz Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Jazz Small Molecule Nucleic Acid Drug Products Offered
10.3.5 Jazz Recent Development
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Company Information
10.4.2 Sarepta Therapeutics Introduction and Business Overview
10.4.3 Sarepta Therapeutics Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sarepta Therapeutics Small Molecule Nucleic Acid Drug Products Offered
10.4.5 Sarepta Therapeutics Recent Development
10.5 Alnylam
10.5.1 Alnylam Company Information
10.5.2 Alnylam Introduction and Business Overview
10.5.3 Alnylam Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Alnylam Small Molecule Nucleic Acid Drug Products Offered
10.5.5 Alnylam Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novartis Small Molecule Nucleic Acid Drug Products Offered
10.6.5 Novartis Recent Development
10.7 Nippon Shinyaku
10.7.1 Nippon Shinyaku Company Information
10.7.2 Nippon Shinyaku Introduction and Business Overview
10.7.3 Nippon Shinyaku Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Nippon Shinyaku Small Molecule Nucleic Acid Drug Products Offered
10.7.5 Nippon Shinyaku Recent Development
10.8 Swedish Orphan Biovitrum
10.8.1 Swedish Orphan Biovitrum Company Information
10.8.2 Swedish Orphan Biovitrum Introduction and Business Overview
10.8.3 Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Products Offered
10.8.5 Swedish Orphan Biovitrum Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Small Molecule Nucleic Acid Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Small Molecule Nucleic Acid Drug Industrial Chain Analysis
11.4 Small Molecule Nucleic Acid Drug Market Dynamics
11.4.1 Small Molecule Nucleic Acid Drug Industry Trends
11.4.2 Small Molecule Nucleic Acid Drug Market Drivers
11.4.3 Small Molecule Nucleic Acid Drug Market Challenges
11.4.4 Small Molecule Nucleic Acid Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Small Molecule Nucleic Acid Drug Distributors
12.3 Small Molecule Nucleic Acid Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antisense Nucleic Acid (ASO)
Table 2. Major Company of Small Interfering Nucleic Acid (siRNA)
Table 3. Major Company of MicroRNA (miRNA)
Table 4. Major Company of Nucleic Acid Aptamer (Aptamer)
Table 5. Major Company of Transfer RNA (tRNA) Fragmentation
Table 6. Global Small Molecule Nucleic Acid Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (K Units)
Table 8. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US& Million)
Table 10. Global Small Molecule Nucleic Acid Drug Market Share in Value by Type (2024-2024)
Table 11. Global Small Molecule Nucleic Acid Drug Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Small Molecule Nucleic Acid Drug Sales by Type (2024-2034) & (K Units)
Table 13. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Small Molecule Nucleic Acid Drug Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type (2024-2034)
Table 16. Global Small Molecule Nucleic Acid Drug Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (K Units)
Table 18. North America Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Small Molecule Nucleic Acid Drug Sales (K Units) by Type (2024-2024)
Table 20. Europe Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Small Molecule Nucleic Acid Drug Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Small Molecule Nucleic Acid Drug Sales (K Units) by Type (2024-2024)
Table 24. Latin America Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Small Molecule Nucleic Acid Drug Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Small Molecule Nucleic Acid Drug Sales by Company (2024-2024) & (K Units)
Table 28. Global Small Molecule Nucleic Acid Drug Sales Share by Company (2024-2024)
Table 29. Global Small Molecule Nucleic Acid Drug Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Small Molecule Nucleic Acid Drug Revenue Share by Company (2024-2024)
Table 31. Global Market Small Molecule Nucleic Acid Drug Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Small Molecule Nucleic Acid Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Small Molecule Nucleic Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Nucleic Acid Drug as of 2022)
Table 35. Date of Key Manufacturers Enter into Small Molecule Nucleic Acid Drug Market
Table 36. Key Manufacturers Small Molecule Nucleic Acid Drug Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Small Molecule Nucleic Acid Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Small Molecule Nucleic Acid Drug Sales by Region (2024-2024) & (K Units)
Table 40. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Small Molecule Nucleic Acid Drug Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Region (2024-2024)
Table 43. Global Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Small Molecule Nucleic Acid Drug Sales by Region (2024-2034) & (K Units)
Table 45. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Small Molecule Nucleic Acid Drug Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Region (2024-2034)
Table 48. Global Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Small Molecule Nucleic Acid Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (K Units)
Table 51. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application (2024-2024)
Table 54. Global Small Molecule Nucleic Acid Drug Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Small Molecule Nucleic Acid Drug Sales by Application (2024-2034) & (K Units)
Table 56. Global Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Small Molecule Nucleic Acid Drug Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application (2024-2034)
Table 59. Global Small Molecule Nucleic Acid Drug Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) (K Units)
Table 61. North America Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) (K Units)
Table 63. Europe Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) (K Units)
Table 67. Latin America Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (K Units)
Table 71. North America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2024)
Table 74. North America Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 75. North America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (K Units)
Table 79. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 83. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Small Molecule Nucleic Acid Drug Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Small Molecule Nucleic Acid Drug Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Value by Country (2024-2034)
Table 110. Biogen Company Information
Table 111. Biogen Introduction and Business Overview
Table 112. Biogen Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Biogen Small Molecule Nucleic Acid Drug Product
Table 114. Biogen Recent Development
Table 115. Pfizer Company Information
Table 116. Pfizer Introduction and Business Overview
Table 117. Pfizer Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Pfizer Small Molecule Nucleic Acid Drug Product
Table 119. Pfizer Recent Development
Table 120. Jazz Company Information
Table 121. Jazz Introduction and Business Overview
Table 122. Jazz Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Jazz Small Molecule Nucleic Acid Drug Product
Table 124. Jazz Recent Development
Table 125. Sarepta Therapeutics Company Information
Table 126. Sarepta Therapeutics Introduction and Business Overview
Table 127. Sarepta Therapeutics Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Sarepta Therapeutics Small Molecule Nucleic Acid Drug Product
Table 129. Sarepta Therapeutics Recent Development
Table 130. Alnylam Company Information
Table 131. Alnylam Introduction and Business Overview
Table 132. Alnylam Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Alnylam Small Molecule Nucleic Acid Drug Product
Table 134. Alnylam Recent Development
Table 135. Novartis Company Information
Table 136. Novartis Introduction and Business Overview
Table 137. Novartis Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Novartis Small Molecule Nucleic Acid Drug Product
Table 139. Novartis Recent Development
Table 140. Nippon Shinyaku Company Information
Table 141. Nippon Shinyaku Introduction and Business Overview
Table 142. Nippon Shinyaku Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Nippon Shinyaku Small Molecule Nucleic Acid Drug Product
Table 144. Nippon Shinyaku Recent Development
Table 145. Swedish Orphan Biovitrum Company Information
Table 146. Swedish Orphan Biovitrum Introduction and Business Overview
Table 147. Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Swedish Orphan Biovitrum Small Molecule Nucleic Acid Drug Product
Table 149. Swedish Orphan Biovitrum Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Small Molecule Nucleic Acid Drug Market Trends
Table 153. Small Molecule Nucleic Acid Drug Market Drivers
Table 154. Small Molecule Nucleic Acid Drug Market Challenges
Table 155. Small Molecule Nucleic Acid Drug Market Restraints
Table 156. Small Molecule Nucleic Acid Drug Distributors List
Table 157. Small Molecule Nucleic Acid Drug Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Molecule Nucleic Acid Drug Product Picture
Figure 2. Global Small Molecule Nucleic Acid Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Small Molecule Nucleic Acid Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Small Molecule Nucleic Acid Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Antisense Nucleic Acid (ASO)
Figure 6. Global Antisense Nucleic Acid (ASO) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Small Interfering Nucleic Acid (siRNA)
Figure 8. Global Small Interfering Nucleic Acid (siRNA) Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of MicroRNA (miRNA)
Figure 10. Global MicroRNA (miRNA) Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Nucleic Acid Aptamer (Aptamer)
Figure 12. Global Nucleic Acid Aptamer (Aptamer) Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Transfer RNA (tRNA) Fragmentation
Figure 14. Global Transfer RNA (tRNA) Fragmentation Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Small Molecule Nucleic Acid Drug Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Small Molecule Nucleic Acid Drug Sales Market Share by Type in 2022 & 2034
Figure 17. North America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type in 2022
Figure 18. North America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type in 2022
Figure 19. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type in 2022
Figure 20. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type in 2022
Figure 23. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Molecule Nucleic Acid Drug Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Small Molecule Nucleic Acid Drug Revenue in 2022
Figure 29. Small Molecule Nucleic Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Specialty Clinic
Figure 33. Global Specialty Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Small Molecule Nucleic Acid Drug Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Small Molecule Nucleic Acid Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Small Molecule Nucleic Acid Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Small Molecule Nucleic Acid Drug Manufacturing Cost Structure
Figure 49. Small Molecule Nucleic Acid Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed